skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:028169/0528   Pages: 19
Recorded: 05/07/2012
Attorney Dkt #:368986-54
Conveyance: SECURITY AGREEMENT
Total properties: 18
1
Patent #:
7968565
Issue Dt:
06/28/2011
Application #:
11080102
Filing Dt:
03/14/2005
Publication #:
US20050215583
Pub Dt:
09/29/2005
Title:
THERAPEUTIC COMBINATIONS COMPRISING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID
2
Patent #:
7989468
Issue Dt:
08/02/2011
Application #:
11080283
Filing Dt:
03/14/2005
Publication #:
US20050203120
Pub Dt:
09/15/2005
Title:
METHODS OF USING SNS-595
3
Patent #:
7829577
Issue Dt:
11/09/2010
Application #:
11478765
Filing Dt:
06/29/2006
Publication #:
US20060247267
Pub Dt:
11/02/2006
Title:
PHARMACEUTICAL COMPOSITIONS OF (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID
4
Patent #:
NONE
Issue Dt:
Application #:
11890196
Filing Dt:
08/02/2007
Publication #:
US20080063642
Pub Dt:
03/13/2008
Title:
Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disorders
5
Patent #:
8580814
Issue Dt:
11/12/2013
Application #:
11991349
Filing Dt:
06/18/2009
Publication #:
US20090263393
Pub Dt:
10/22/2009
Title:
METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID FOR TREATMENT OF CANCER
6
Patent #:
8124773
Issue Dt:
02/28/2012
Application #:
12304750
Filing Dt:
06/05/2009
Publication #:
US20100029708
Pub Dt:
02/04/2010
Title:
1,8-NAPHTHYRIDINE COMPOUNDS FOR THE TREATMENT OF CANCER
7
Patent #:
NONE
Issue Dt:
Application #:
12376118
Filing Dt:
11/09/2009
Publication #:
US20100048609
Pub Dt:
02/25/2010
Title:
PHARMACEUTICAL DOSAGE FORMS FOR (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID
8
Patent #:
8497282
Issue Dt:
07/30/2013
Application #:
12650390
Filing Dt:
12/30/2009
Publication #:
US20100203162
Pub Dt:
08/12/2010
Title:
Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
9
Patent #:
8518872
Issue Dt:
08/27/2013
Application #:
12739139
Filing Dt:
08/09/2010
Publication #:
US20100297142
Pub Dt:
11/25/2010
Title:
METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID IN COMBINATION THERAPY
10
Patent #:
NONE
Issue Dt:
Application #:
12747167
Filing Dt:
09/09/2010
Publication #:
US20110008371
Pub Dt:
01/13/2011
Title:
METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID FOR TREATMENT OF ANTECEDENT HEMATOLOGIC DISORDERS
11
Patent #:
8586601
Issue Dt:
11/19/2013
Application #:
12875927
Filing Dt:
09/03/2010
Publication #:
US20110082169
Pub Dt:
04/07/2011
Title:
Stable SNS-595 Compositions and Methods of Preparation
12
Patent #:
8470817
Issue Dt:
06/25/2013
Application #:
12912617
Filing Dt:
10/26/2010
Publication #:
US20110105497
Pub Dt:
05/05/2011
Title:
COMPOUNDS AND METHODS FOR TREATMENT OF CANCER
13
Patent #:
8138202
Issue Dt:
03/20/2012
Application #:
12982785
Filing Dt:
12/30/2010
Publication #:
US20110086876
Pub Dt:
04/14/2011
Title:
STABLE SNS-595 COMPOSITIONS AND METHODS OF PREPARATION
14
Patent #:
NONE
Issue Dt:
Application #:
13095111
Filing Dt:
04/27/2011
Publication #:
US20110263524
Pub Dt:
10/27/2011
Title:
SNS-595 AND METHODS OF USING THE SAME
15
Patent #:
8669270
Issue Dt:
03/11/2014
Application #:
13159258
Filing Dt:
06/13/2011
Publication #:
US20110312988
Pub Dt:
12/22/2011
Title:
SNS-595 AND METHODS OF USING THE SAME
16
Patent #:
NONE
Issue Dt:
Application #:
13203718
Filing Dt:
03/02/2012
Publication #:
US20120148564
Pub Dt:
06/14/2012
Title:
METHODS OF USING SNS-595 FOR TREATMENT OF CANCER SUBJECTS WITH REDUCED BRCA2 ACTIVITY
17
Patent #:
8765954
Issue Dt:
07/01/2014
Application #:
13360558
Filing Dt:
01/27/2012
Publication #:
US20120245198
Pub Dt:
09/27/2012
Title:
1,8-NAPHTHYRIDINE COMPOUNDS FOR THE TREATMENT OF CANCER
18
Patent #:
NONE
Issue Dt:
Application #:
60921500
Filing Dt:
09/02/2005
Publication #:
US20060025437
Pub Dt:
02/02/2006
Title:
SNS-595 and methods of using the same
Assignor
1
SUNESIS PHARMACEUTICALS, INC.
Exec Dt:
03/29/2012
Assignee
1
OXFORD FINANCE LLC, AS COLLATERAL AGENT
133 NORTH FAIRFAX STREET
ATTENTION: LEGAL DEPARTMENT
ALEXANDRIA, VIRGINIA 22314
Correspondence name and address
DLA PIPER LLP (US)
4365 EXECUTIVE DRIVE, SUITE 1100
ATTENTION: SUSAN REYNHOLDS
SAN DIEGO, CA 92121

Search Results as of: 05/14/2024 07:35 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT